Infectious Agents and Cancer (Oct 2010)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

  • Blasberg Ronald,
  • Wang Lynn,
  • Chiosis Gabriela,
  • Cerchietti Leandro,
  • Vider Jelena,
  • Lu Pin,
  • Nayar Utthara,
  • Cesarman Ethel

DOI
https://doi.org/10.1186/1750-9378-5-S1-A36
Journal volume & issue
Vol. 5, no. Suppl 1
p. A36

Abstract

Read online

No abstracts available.